CFGS
MRNA icon

Concourse Financial Group Securities’s Moderna MRNA Stock Holding History

Concourse Financial Group Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-601
Closed -$23.1K – 1313
2024
Q4 		$23.1K Sell
601
-49
-8% -$2.34K ﹤0.01% 1506
2024
Q3 		$43.4K Sell
650
-151
-19% -$13.9K ﹤0.01% 1235
2024
Q2 		$95.1K Buy
801
+2
+0.3% +$253 0.01% 946
2024
Q1 		$85.1K Buy
799
+25
+3% +$2.52K 0.01% 976
2023
Q4 		$77K Sell
774
-20
-3% -$1.68K 0.01% 986
2023
Q3 		$82K Sell
794
-136
-15% -$15.2K 0.01% 913
2023
Q2 		$113K Buy
930
+176
+23% +$23.5K 0.01% 843
2023
Q1 		$116K Sell
754
-66
-8% -$10.9K 0.01% 825
2022
Q4 		$147K Sell
820
-9
-1% -$1.47K 0.01% 706
2022
Q3 		$98K Buy
829
+334
+67% +$50.7K 0.01% 730
2022
Q2 		$71K Sell
495
-52
-10% -$7.43K 0.01% 942
2022
Q1 		$94K Sell
547
-454
-45% -$76.4K 0.01% 891
2021
Q4 		$254K Sell
1,001
-58
-5% -$17K 0.01% 652
2021
Q3 		$408K Sell
1,059
-233
-18% -$85.9K 0.02% 511
2021
Q2 		$303K Buy
1,292
+136
+12% +$24.3K 0.02% 589
2021
Q1 		$151K Buy
1,156
+24
+2% +$3.48K 0.01% 771
2020
Q4 		$118K Buy
1,132
+397
+54% +$40.2K 0.01% 817
2020
Q3 		$52K Buy
735
+143
+24% +$9.97K ﹤0.01% 1046
2020
Q2 		$38K Buy
+592
New +$32.4K ﹤0.01% 1077

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Concourse Financial Group Securities's MRNA Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Moderna (MRNA) in Q1 2025, closing a stake of 601 shares — an estimated $23.1K sold.

Concourse Financial Group Securities first reported a position in MRNA in Q2 2020 and held it in 19 quarters. The position peaked at $408K in Q3 2021. 694 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 601 Moderna shares in Q1 2025, an estimated $23.1K.
  • Concourse Financial Group Securities first reported a position in Moderna in Q2 2020 and held it in 19 quarters.
  • Concourse Financial Group Securities's Moderna position peaked at $408K in Q3 2021.
  • 694 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.